NCPA: Oversight PBM Hearing, report demand reforms and enforcement
ALEXANDRIA, Va. – The National Community Pharmacists Association released the following statement today from its CEO, B.
Pharmacy
CVS Caremark defines future of pharmacy benefit management
CVS Caremark today announced a renewed pledge to American businesses, unions, and health plans — building on what the company is doing to deliver greater transparency, lower drug costs, and better clinical care for the most utilized health benefit.
Aurobindo gets FDA approval for dutasteride and tamsulosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for dutasteride and tamsulosin hydrochloride capsules 0.5 mg/0.4 mg.
Aurobindo receives FDA approval for baricitinib tablets
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application baricitinib tablets, 1mg and 2mg.
NACDS: House Oversight Hearing fuels PBM reform’s “must-pass” status
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today hailed the U.S.
Supply chain experts discuss the future of the U.S. pharmaceutical cold chain
Manufacturing, distributing and delivering cold chain pharmaceuticals poses unique challenges and opportunities for the healthcare supply chain.
PCMA issues statement on House Oversight Hearing
The Pharmaceutical Care Management Association (PCMA) released the following statement ahead of the U.S.
Walgreens gets BARDA Project NextGen Award for new study
Walgreens has received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will
Amid House oversight hearing, pharmacy organizations issue united call for action on ‘must-pass’ PBM reform legislation
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S.
Aurobindo receives FDA nod for posaconazole delayed-release tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application posaconazole delayed-release tablets 100mg.
Shoppers Drug Mart partners with Truvian Health
Shoppers Drug Mart has agreed to a commercial partnership with San Diego, Calif.-based blood testing startup Truvian Health. Truvian has created a printer-sized device that enables practitioners to perform a blood test in less than 40 minutes without sending the sample to a different lab.
Boehringer Ingelheim and GoodRx partner
RIDGEFIELD, Conn. – Boehringer Ingelheim and GoodRx, the leading prescription savings platform in the U.S., announced today a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer’s biosimilar to Humira (adalimumab), at a low cash price available exclusively on GoodRx.
NACDS seeks participants for PBM hearing ‘watch party’
The National Association of Chain Drug Stores issued the following statement in advance of the House hearing next week on PBM practices: NACDS RxIMPACT needs YOUR help today to make sure the U.S.